Lazard Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.2M	Sell	93,620 -5,144	-5%	-$65.5K	﹤0.01%	1104
2025 Q4	$888K	Sell	98,764 -15,850	-14%	-$218K	﹤0.01%	1193
2025 Q3	$1.98M	Buy	114,614 +22,184	+24%	+$273K	﹤0.01%	860
2025 Q2	$866K	Sell	92,430 -15,627	-14%	-$128K	﹤0.01%	1345
2025 Q1	$768K	Sell	108,057 -1,443	-1%	-$14.6K	﹤0.01%	1298
2024 Q4	$1.28M	Buy	109,500 +7,488	+7%	+$117K	﹤0.01%	1048
2024 Q3	$2.1M	Sell	102,012 -14,378	-12%	-$332K	﹤0.01%	862
2024 Q2	$2.6M	Buy	116,390 +26,332	+29%	+$627K	﹤0.01%	813
2024 Q1	$2.48M	Sell	90,058 -12,175	-12%	-$338K	﹤0.01%	803
2023 Q4	$3.12M	Sell	102,233 -3,917	-4%	-$113K	﹤0.01%	778
2023 Q3	$3.35M	Sell	106,150 -1,329	-1%	-$51.6K	﹤0.01%	780
2023 Q2	$4.38M	Buy	107,479 +1,021	+1%	+$41.4K	0.01%	730
2023 Q1	$3.97M	Buy	106,458 +58,951	+124%	+$2.31M	0.01%	774
2022 Q4	$1.66M	Sell	47,507 -39,889	-46%	-$1.9M	﹤0.01%	927
2022 Q3	$4.89M	Buy	87,396 +4,971	+6%	+$308K	0.01%	719
2022 Q2	$4.27M	Buy	82,425 +81,876	+14,914%	+$4.16M	0.01%	765
2022 Q1	$39K	Buy	549 +146	+36%	+$12.4K	﹤0.01%	1860
2021 Q4	$47K	Buy	403 +393	+3,930%	+$49.2K	﹤0.01%	1767
2021 Q3	$1K	Buy	+10	New	+$1.51K	﹤0.01%	2131